The Latin American Pharmaceutical Market is expected to grow at a CAGR of 9.3% in the first half of the forecast period. In 2017, the Brazilian Pharmaceutical market accounted for 35.1% of the Latin American Pharmaceutical market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 150-page report you will receive 69 tables and 60 figures– all unavailable elsewhere.
The 150-page report provides clear detailed insight into the Latin American Pharmaceutical Market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Latin American Pharmaceutical Market forecasts from 2018-2028
• This report also breaks down the revenue forecast for the Latin American Pharmaceutical Market by Submarket:
– Generics
– OTC
– Biosimilars
– Originator Drugs
• This report also breaks down the revenue forecast for the Latin American Pharmaceutical Market by Country:
– Brazil
– Mexico
– Venezuela
– Argentina
– Colombia
– Chile
– Rest of Latin America
Each country is further segmented into Generics, OTC, Biosimilars and Originator Drugs.
• Our study provides a SWOT Analysis of the Latin American Pharmaceutical Market.
• Our study discusses the selected leading companies that are the major players in the Latin American Pharmaceutical Market:
– Pfizer
– Bayer
– Sanofi
– Novartis
– EMS
Visiongain’s study is intended for anyone requiring commercial analyses for the Latin American Pharmaceutical Market. You find data, trends and predictions.
Buy our report today Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Latin American Pharmaceutical Market: Overview
1.2 Latin American Pharmaceutical Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Study
1.6 Who is This Investigation For?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQs)
1.9 Some Associated Reports
1.10 About Visiongain
2. Introduction to the Latin American Pharmaceutical Market
2.1 Introduction to the Global Pharmaceutical Market
2.2 The Latin American Pharmaceutical Market 2017
2.2.1 Definition of Latin America
2.2.2 Regional Trade Bodies and Intergovernmental Organisations
2.2.2.1 Mercado Común del Sur/Mercado Comum do Sul (Mercosur)
2.2.2.2 The Andean Community (CAN)
2.2.2.3 The Union of South American Nations (USAN)
2.2.2.4 The Pacific Alliance
2.2.2.5 Bolivarian Alliance for the Peoples of Our America (ALBA)
3. The Latin American Pharmaceutical Market, 2018-2028
3.1 The Latin American Pharmaceutical Market Forecast, 2018-2028
3.2Factors Affecting the Latin American Pharmaceutical Market
3.2.1 Population Growth and Ageing
3.2.2 Economic Conditions
3.2.3 Trans-Pacific Partnership (TPP)
3.3 The Latin American Pharmaceutical Market Breakdown, 2018-2028
3.3.1 The Latin American Generic Drugs Market Forecast, 2018-2028
3.3.2 The Latin American OTC Market Forecast, 2018-2028
3.3.3 The Latin American Biosimilars Market Forecast, 2018-2028
3.3.4 Latin American Originator Drugs Market Forecast, 2018-2028
3.4 SWOT Analysis of the Latin American Pharmaceutical Market, 2018-2028
3.4.1 Strengths
3.4.1.1 One of the Quickest Growing Markets Globally
3.4.1.2 Increasing Incidence of Chronic Diseases
3.4.1.3 Ageing Population
3.4.1.4 Increasing Investment in Health Care Systems
3.4.2 Weaknesses
3.4.2.1 Poor Economic Performance and Devalued Currencies
3.4.2.2 Weak Regulation
3.4.2.3 Weak IP Protection
3.4.3 Opportunities
3.4.3.1 Emerging Biosimilars Market
3.4.3.2 Regional Pharmaceutical Companies Could Expand Outside Latin America
3.4.3.3 Increased Trade Liberalisation Could Open More Markets
3.4.4 Threats
3.4.4.1 Pharmaceutical Companies from Other Emerging Markets Could Challenge Regional Firms
3.4.4.2 Increased Protectionist Measures Could Severely Harm the Industry
3.4.4.3 Further Economic Problems and Currency Devaluations Possible
4. Latin American National Markets, 2018-2028
4.1 Latin American National Markets, 2017
4.2 Latin American National Pharmaceutical Market Forecasts, 2018-2028
4.3 Leading National Markets Shares of the Latin American Pharmaceutical Market
4.3.1 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2017
4.3.2 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2023
4.3.3 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2028
5. The Brazilian National Pharmaceutical Market, 2018-2028
5.1 The Brazilian National Pharmaceutical Market, 2017
5.2 The Brazilian National Pharmaceutical Sub-Market Forecasts, 2018-2028
5.2.1 The Brazilian National Pharmaceutical Market Forecast, 2018-2028
5.2.2The Brazilian Generic Drugs Market Forecast, 2018-2028
5.2.3 The Brazilian OTC Market Forecast, 2018-2028
5.2.4 The Brazilian Biosimilars Market Forecast, 2018-2028
5.2.5 The Brazilian Originator Drugs Market Forecast, 2018-2028
5.3 The Brazilian National Pharmaceutical - Current Currency Fluctuations
6. The Mexican National Pharmaceutical Market, 2018-2028
6.1 The Mexican National Pharmaceutical Market, 2017
6.2 The Mexican National Pharmaceutical Sub-Market Forecasts, 2018-2028
6.2.1 The Mexican National Pharmaceutical Market Forecast, 2018-2028
6.2.2 The Mexican Generic Drugs Market Forecast, 2018-2028
6.2.3 The Mexican OTC Market Forecast, 2018-2028
6.2.4 The Mexican Biosimilars Market Forecast, 2018-2028
6.2.5 The Mexican Originator Drugs Market Forecast, 2018-2028
7. The Venezuelan National Pharmaceutical Market, 2018-2028
7.1 The Venezuelan National Pharmaceutical Market, 2018
7.2 The Venezuelan National Pharmaceutical Market Breakdown Forecast, 2018-2028
7.2.1 The Venezuelan National Pharmaceutical Market Forecast, 2018-2028
7.2.2 The Venezuelan Generic Drugs Market Forecast, 2018-2028
7.2.3 The Venezuelan OTC Market Forecast, 2018-2028
7.2.4 The Venezuelan Biosimilars Market Forecast, 2018-2028
7.2.5 The Venezuelan Originator Drugs Market Forecast, 2018-2028
8. The Argentine National Pharmaceutical Market, 2018-2028
8.1 The Argentine National Pharmaceutical Market, 2017
8.2 The Argentine National Pharmaceutical Market Breakdown, 2018-2028
8.2.1 The Argentine National Pharmaceutical Market Forecast, 2018-2028
8.2.2 The Argentine Generic Drugs Market Forecast, 2018-2028
8.2.3 The Argentine OTC Market Forecast, 2018-2028
8.2.4 The Argentine Biosimilars Market Forecast, 2018-2028
8.2.5 The Argentine Originator Drugs Market Forecast, 2018-2028
9. The Colombian National Pharmaceutical Market, 2018-2028
9.1 The Colombian National Pharmaceutical Market, 2017
9.2 The Colombian National Pharmaceutical Market Breakdown, 2018-2028
9.2.1 The Colombian National Pharmaceutical Market Forecast, 2018-2028
9.2.1.1 Economic Growth and Financial Constraints
9.2.1.2 Introduction of the Statutory Health Law
9.2.2 The Colombian Generic Drugs Market Forecast, 2018-2028
9.2.3 The Colombian OTC Market Forecast, 2018-2028
9.2.4 The Colombian Biosimilars Market Forecast, 2018-2028
9.2.5 The Colombian Originator Drugs Market Forecast, 2018-2028
10. The Chilean National Pharmaceutical Market, 2018-2028
10.1 The Chilean National Pharmaceutical Market, 2018
10.1.1 The Chilean Health Care System
10.1.2 Majority of Generic Revenue from Branded Generics
10.2 The Chilean National Pharmaceutical Market Breakdown, 2018-2028
10.2.1 The Chilean National Pharmaceutical Market Forecast, 2018-2028
10.2.2 The Chilean Generic Drugs Market Forecast, 2018-2028
10.2.3 The Chilean OTC Market Forecast, 2018-2028
10.2.4 The Chilean Biosimilars Market Forecast, 2018-2028
10.2.5 The Chilean Originator Drugs Market Forecast, 2018-2028
11. The Rest of the Latin American Pharmaceutical Market, 2018-2028
11.1 The Rest of the Latin American Pharmaceutical Market, 2017
11.2 The Rest of the Latin American Pharmaceutical Market Breakdown, 2018-2028
12. Top Five Pharmaceutical Companies in Latin America
12.1 Bayer AG
12.1.1 Bayer AG: Company Overview
12.1.2 Bayer AG: Product Portfolio
12.1.3 Bayer AG: Recent Developments
12.2 Pfizer Inc.
12.2.1 Pfizer Inc.: Company Overview
12.2.2 Pfizer Inc.: Product Portfolio
12.3 Sanofi S.A.
12.3.1 Sanofi S.A.: Company Overview
12.3.2 Sanofi S.A.: Product Portfolio
12.3.3 Sanofi S.A: Recent Developments
12.4 Novartis AG
12.4.1 Novartis AG: Company Overview
12.4.2 Novartis AG: Product Portfolio
12.5 EMS SA
12.5.1 EMS SA: Company Overview
13. Conclusions
13.1 The Latin American Pharmaceutical Market, 2017-2018
13.2 Latin American Pharmaceutical Market Forecast, 2018-2028
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form
List of Tables
Table 2.1 Market Share (%) of the Global Pharmaceutical Market by Region, 2017
Table 2.2 Population Sizes of Latin American Countries/Regions and Percentage of Total Population (%), 2017
Table 3.1 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.2 Percentage (%) of Population Over 65 Years Old in Key Latin American Markets and Segment Average, 2010 and 2050
Table 3.3 The Latin American Pharmaceutical Market Breakdown by Submarket, Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.4 The Latin American Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.5 The Latin American OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.6 The Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2018-2028
Table 3.7 The Latin American Originator Drugs Market: Revenue($bn), AGR (%) and CAGR (%), 2018-2027
Table 3.8 SWOT Analysis of the Latin American Pharmaceutical Market, 2018-2028
Table 4.1 Market Revenues ($bn) of the Six Largest Pharmaceutical Markets in Latin America, 2017
Table 4.2 The Latin American National Pharmaceutical Market by Country: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 4.3 National Market Revenues ($bn) and Latin American Market Shares (%) by Country, 2017
Table 4.4 National Market Revenues ($bn) and Latin American Market Shares (%), 2023
Table 4.5 National Market Revenues ($bn) and Latin American Market Shares (%), 2028
Table 5.1 Brazilian National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.2 Brazilian National Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.3 Brazilian Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.4 Brazilian OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.5 Brazilian Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 5.6 Brazilian Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.1 Mexican National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.2 Mexican National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.3 Mexican Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.4 Mexican OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.5 Mexican Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 6.6 Mexican Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.1 Venezuelan National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.2 Venezuelan National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.3 Venezuelan Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.4 Venezuelan OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.5 Venezuelan Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 7.6 Venezuelan Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.1 Argentine National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.2 Argentine National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.3 Argentine Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.4 Argentine OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.5 Argentine Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 8.6 Argentine Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.1 Colombian National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.2 Colombian National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.3 Colombian Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.4 Colombian OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.5 Colombian Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 9.6 Colombian Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2017
Table 10.2 Chilean National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.3 Chilean National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.4 Chilean Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.5 Chilean OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.6 Chilean Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 10.7 Chilean Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.1 The Rest of the Latin American Pharmaceutical Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.2 Rest of the Latin American Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.3 Rest of the Latin American Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.4 Rest of the Latin American OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.5 Rest of the Latin American Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 11.6 Rest of the Latin American Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
Table 12.1 Bayer AG: Company Overview
Table 12.2 Bayer AG: Product Portfolio
Table 12.3 Bayer AG: Recent Developments
Table 12.4 Pfizer Inc.: Company Overview
Table 12.5 Pfizer Inc.: Product Portfolio
Table 12.6 Sanofi S.A.: Company Overview
Table 12.7 Novartis AG: Company Overview
Table 12.8 Novartis AG: Product Portfolio
Table 12.9 EMS SA: Company Overview
Table 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), 2017-2018
Table 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028
List of Figures
Figure 1.2 Key Markets within the Latin American Pharmaceutical Market
Figure 1.3 Key Product Types within the Latin American Pharmaceutical Market
Figure 2.1 Market Shares (%) of Pharmaceutical Market by Region, 2017
Figure 2.2 Population Sizes of Latin American Countries/Regions by Percentage (%), 2017
Figure 3.1 The Latin American Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.2 The Latin American Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.3 The Latin American OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.4 The Latin American Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 3.5 The Latin American Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 4.1 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2017
Figure 5.1 Brazilian National Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.2 Brazilian Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.3 Brazilian OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.4 Brazilian Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 5.5 Brazilian Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.1 Mexican National Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.2 Mexican Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.3 Mexican OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.4 Mexican Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 6.5 Mexican Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 7.1 Venezuelan National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 7.2 Venezuelan Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 7.3 Venezuelan OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 7.4 Venezuelan Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 7.5 Venezuelan Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 8.1 Argentine National Pharmaceutical Market: Revenue($bn) and AGR (%), 2018-2028
Figure 8.2 Argentine Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 8.3 Argentine OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 8.4 Argentine Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 8.5 Argentine Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 9.1 Colombian National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 9.2 Colombian Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 9.3 Colombian OTC Market: Revenue($bn) and AGR (%), 2018-2028
Figure 9.4 Colombian Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 9.5 Colombian Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2017
Figure 10.2 Chilean National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 10.3 Chilean Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 10.4 Chilean OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 10.5 Chilean Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 10.6 Chilean Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 11.1 Rest of the Latin American National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 11.2 Rest of the Latin American Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 11.3 Rest of the Latin American OTC Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 11.4 Rest of the Latin American Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 11.5 Rest of the Latin American Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
Figure 12.1 Bayer AG, Revenue, ($million), 2012-2016
Figure 12.2 Bayer AG, Product Segments Share (%), 2016
Figure 12.3 Bayer AG, Geographic Presence Share (%), 2016
Figure 12.4 Pfizer Inc., Revenue, ($million), 2012-2016
Figure 12.5 Pfizer Inc., Product Segments Share (%), 2016
Figure 12.6 Pfizer Inc., Geographical Presence Share (%), 2016
Figure 12.7 Sanofi S.A., Revenue, ($million), 2012-2016
Figure 12.8 Sanofi S.A., Product Segments Share (%), 2016
Figure 12.9 Sanofi S.A., Geographical Presence Share (%), 2016
Figure 12.10 Novartis AG, Revenue, ($million), 2012-2016
Figure 12.11 Novartis AG, Product Segments Share (%), 2016
Figure 12.12 Novartis AG, Geographical Presence Share (%), 2016
Figure 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), 2017-2018
Figure 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), 2017-2028
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
